SCHEDULE: Biodesix Insider Boosts Stake to 27% After Reverse Split

Jack W. Schuler, a significant insider, increased his beneficial ownership in Biodesix Inc. to 27.0% following recent share purchases and a reverse stock split.

Summary

• Jack W. Schuler's beneficial ownership in Biodesix Inc. increased to 2,151,480 shares, representing approximately 27.0% of the common stock outstanding.
• This ownership includes 20,735 shares acquirable within 60 days (4,156 from options and 16,579 from vested RSUs), 1,380,745 shares held by the Jack W. Schuler Living Trust, and 750,000 shares held by the Jack W. Schuler 2025 GRAT.
• The company effected a one-for-twenty reverse stock split on September 15, 2025, and all reported share numbers are adjusted for this.
• Recent purchases by Mr. Schuler through the Trust include 15,317 shares on September 17, 2025, at a weighted average price of $6.0437, 3,056 shares on September 18, 2025, at a weighted average price of $6.1695, and 142,045 shares on September 19, 2025, at $7.04 per share for an aggregate of $999,996.80.
• The total shares outstanding used for percentage calculation is 7,954,541 as of September 22, 2025, plus 20,735 shares Mr. Schuler has the right to acquire.

Sentiment

Score: 8

Explanation: The substantial increase in beneficial ownership by a key insider, Jack W. Schuler, to 27.0% through recent purchases, including a significant acquisition in an at-the-market offering, indicates strong confidence and a positive outlook from a knowledgeable party. This insider buying, especially after a reverse stock split, is generally perceived as a bullish signal.

Positives

• Significant insider buying by Jack W. Schuler, increasing his stake to 27.0%, signals strong confidence in the company's future.
• The purchases were made using Mr. Schuler's personal funds, indicating direct financial commitment.
• The acquisition of 142,045 shares in an at-the-market offering suggests a strategic move to increase ownership at a specific price point.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future operations or financial performance, focusing solely on beneficial ownership changes.

Industry Context

Increased insider ownership, especially by a substantial shareholder like Jack W. Schuler, can be viewed positively in the biotech and diagnostics industry, signaling confidence in the company's long-term prospects and technology amidst competitive pressures and regulatory landscapes. This move could suggest a belief in the company's ability to navigate market challenges and capitalize on future growth opportunities.

Comparison to Industry Standards

• The filing does not provide specific data points that allow for direct comparison to global benchmarks or specific comparable companies or projects.
• A 27.0% beneficial ownership by a single insider is a substantial stake, often higher than typical institutional or individual insider holdings in many publicly traded companies, suggesting a high level of conviction.

Stakeholder Impact

• Shareholders: Increased insider ownership may instill confidence, potentially signaling a positive outlook for the stock.
• Management: A large insider stake can align management's interests more closely with long-term shareholder value.

Key Dates

Recommendation

The significant increase in beneficial ownership by a key insider, Jack W. Schuler, to 27.0% through recent open market and at-the-market purchases, particularly after a reverse stock split, is a strong indicator of insider confidence. Such substantial insider buying, funded by personal funds, often suggests that the insider believes the stock is undervalued or expects positive developments, making it an attractive 'buy' signal for seasoned investors.

Keywords

Biodesix, Jack W. Schuler, Insider Ownership, Schedule 13D, Reverse Stock Split, Common Stock, Share Purchase, Beneficial Ownership, Biotech, Diagnostics